Health related quality of life in patients with type I diabetes mellitus: Generic & disease-specific measurement

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 203-216

  Hart, Huberta E ^a   Redekop, William K ^a   Bilo, Henk J G ^b   Meyboom de Jong, Betty ^c   Berg, Marc ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Diabetes mellitus type I; EuroQol; Health related quality of life; Hypoglycaemia fear scale; RAND 36

Indexed keywords

INSULIN;

ADULT; ARTICLE; CORRELATION ANALYSIS; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE;

EID: 34249337105     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-18.
2. Bradley C. Measuring quality of life in diabetes. The Diabetes Annual 1996; 10: 207-24.
3. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of quality-of-life instruments. Pharmacoeconomics 2000; 17: 13-35.
4. Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome for measures for diabetes: a structured review. Diabet Med 2002; 19: 1-11.
5. Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Qual Life Res 2000; 9: 207-18.
6. Luscombe FA. Health-related quality of measurement in type 2 diabetes. Value Health 2000; 3 (Suppl 1):15-28.
7. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9.
8. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 (3 Suppl): S217-32.
9. EuroQol Group. EuroQol - a new facility for the measurement of health related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
10. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems: Health Utility Index. Pharmacoeconomics 1995; 7: 490-502.
11. Kaplan RM, Ganiats TG, Rosen P, Sieber W, Anderson JP. Development of a self administered Quality of Well-Being scale (QWB-SA). Qual Life Res 1995; 4: 443-4.
12. Aalto AM, Uutela A, Kangas T. Health behaviour, social integration, perceived health and dysfunction. A comparison between patients with type I and II diabetes and controls. Scand J Soc Med 1996; 24: 272-81.
13. Aalto AM, Uutela A, Aro AR. Health related quality of life among insulin-dependent diabetics: disease-related and psychosocial correlates. Patient Educ Couns 1997; 30: 215-25.
14. Bardsley MJ, Astell S, McCallum A, Home PD. The performance of three measures of health status in an outpatient diabetes population. Diabet Med 1993; 10: 619-26.
15. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-69.
16. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20: 562-7.
17. Hanestad BR. Self-reported quality of life and the effect of different clinical and demographic characteristics in people with type 1 diabetes. Diabetes Res Clin Pract 1993; 19: 139-49.
18. Hart HE, Bilo HJG, Redekop WK, Stolk RP, Assink JH, Meyboom-de Jong B. Quality of life of patients with type I diabetes mellitus. Qual Life Res 2003; 12: 1089-97.
19. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267-74.
20. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res 1997; 6: 11-20.
21. Hahl J, Hamalainen H, Sintonen H, Simell T, Arinen S, Simell O. Health related quality of life in type I diabetes without or with symptoms of long-term complications. Qual Life Res 2002; 11: 427-36.
22. Kent LA, Gill GV, Williams G. Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis. Lancet 1994; 344: 778-81.
23. Muhlhauser I, Overmann H, Bender R, Bott U, Jorgens V, Trautner C, et al. Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus - a population-based study. Diabetologia 1998; 41: 1139-50.
24. Parkerson GR, Jr., Connis RT, Broadhead WE, Patrick DL, Taylor TR, Tse CK. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care 1993; 31: 629-39.
25. Reviriego J, Millan MD, Millan M. Evaluation of the diabetes quality-of-life questionnaire in a Spanish population. An experience of translation and reliability. Pharmacoeconomics 1996; 10: 614-22.
26. Wandell PE, Brorsson B, Aberg H. Quality of life among diabetic patients in Swedish primary health care and in the general population: comparison between 1992 and 1995. Qual Life Res 1998; 7: 751-60.
27. Wikblad K, Leksell J, Wibell L. Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus. Qual Life Res 1996; 5: 123-30.
28. Wu SY, Sainfort F, Tomar RH, Tollios JL, Fryback DG, Klein R, et al. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life. Diabetes Care 1998; 21: 725-31.
29. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-21.
30. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item Health Survey 1.0. Health Econ 1993; 2: 217-27.
31. Welch GW, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care 1997; 20: 760-6.
32. Hays RD, Morales LS. The RAND-36 measure of health related quality of life. Ann Med 2001; 33: 350-7.
33. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33 (4 Suppl): AS264-79.
34. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68.
35. Vander Zee KI, Sanderman R, Heyink J, de Haes H. The psychometric qualities of the RAND 36-item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med 1996; 3: 104-22.
36. Dolan P. Modeling valuations for EuroQol Health States. Med Care 1997; 35: 1095-108.
37. Essink-Bot ML, Stouthard ME, Bonsel GJ. Generalizability of valuations on health states collected with the EuroQol-questionnaire. Health Econ 1993; 2: 237-46.
38. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care 1995; 18: 754-60.
39. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 2000; 23: 1305-9.
40. Irvine A, Cox D, Gonder-Frederick L. The fear of hypoglycaemia scale (HFS). In: Bradley C, editor. Handbook of psychology of diabetes: A guide to psychological measurement in diabetes research and practice. Chur, Switzerland: Hardwood Academic Publishers; 1994 p. 133-55.
41. Snoek F, Pouwer F, Mollema E, Heine R. The Dutch version of the Hypoglycaemia Fear Survey; Internal consistency and validity. Gedrag Gezond 1996; 24: 287-92.
42. Dutch Advisory on Health Research. Advice on chronic diseases: priorities for research's. Gravenhage, the Netherlands; 1991.
43. de Jong PTVM. Screening op diabetische retinopathie [Screening for diabetic retinopathy]. Ned Tijdschr Geneeskd 1993; 137: 1701-5.
44. Holewski JJ, Stess RM, Graf PM, Grunfeld C. Aesthesiometry: quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. J Rehabil Res Dev 1988; 25: 1-10.
45. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-9.
46. EURODIAB. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-85.
47. Dutch Institute for Healthcare Improvement CBO, Dutch Diabetes Federation. Diabetic retinopathy, diabetic nephrophathy, diabetic foot, cardiac and vascular pathology in diabetes mellitus. Utrecht, The Netherlands: Dutch Institute of Healthcare Improvement CBO; 1998.
48. Terwee C, Dekker F, Wiersinga W, Prummel M, Bossuyt P. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation. Qual Life Res 2003; 12: 349-62.
49. Brook RH, Ware JE, Rogers WH, Keeler EB, Davies AR, Donald CA, et al. Does free care improve adults' health? Results from a Randomized Controlled Trial. N Engl J Med 1983; 309: 1426-34.
50. Ware JE, Kosinki M. Interpreting SF-36 summary health measures: A response. Qual Life Res 2001; 10: 405-13.
51. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273: 59-65.
52. Clarke P. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002; 22: 340-9.
53. Jenkinson C, Gray A, Doll H, Lawrence K, Keoghane S, Layte R. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures. Med Care 1997; 35: 1109-18.
54. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabetic Med 2003; 20: 69-72.
55. Woodcock A, Julious SA, Kinmouth AL, Campbell MJ. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res 2001; 10: 661-70.
56. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 2000; 13: 36-45.
57. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91.